• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA approves first U.S. bird flu vaccine for humans

April 17, 2007

The U.S. Food and Drug Administration announced approval of the nation?s first human vaccine for H5N1 influenza, commonly known as avian or bird flu.

Washington, D.C. - 4/17/07 - The U.S. Food and Drug Administration announced approval of the nation's first human vaccine for H5N1 influenza, commonly known as avian or bird flu.

Obtained from a human strain and intended for immunizing 18- to 64-year-olds at risk for increased exposure to the virus, the vaccine consists of two intramuscular injections given one month apart.

The manufacturer, sanofi pasteur, Inc., refuses to sell the vaccine commercially, so the federal government purchased vaccines to be included with the U.S. Strategic National Stockpile for distribution by public health officials, if needed.

The vaccine can be used if the current H5N1 avian virus develops the ability to spread from human to human, causing an influenza pandemic. It may also provide early limited protection until a vaccine tailored to the pandemic strain is developed and administered.

"The threat of an influenza pandemic is, at present, one of the most significant public health issues our nation and world faces," says Andrew C. von Eschenbach, M.D. and FDA commissioner. "The approval of this vaccine is an important step forward in our progression against a pandemic."

Advertisement

The H5N1 virus is one version of the influenza A virus commonly found in birds. While seasonal influenza infection ranges from mild to serious symptoms in most people, the disease caused by H5N1 is more severe and happens quickly, with pneumonia and multi-organ failure commonly seen.

While there have been no reported human cases of H5N1 infection in the US, almost 300 people worldwide have been infected since 2003 and more than half have died. H5N1 has remained primarily an animal disease, but if the virus acquires the ability for sustained transmission, a pandemic could arise because of humans' weak immunity to the strain.

"The timing and severity of an influenza pandemic is uncertain, but the danger remains very real," says Jesse L. Goodman, MD, MPH and director for the FDA's Center for Biologics Evaluation and Research. "We are working closely with other government agencies, global partners and the vaccine industry to facilitate the development, licensure and availability of needed supplies of safe and effective vaccines to protect against the pandemic threat."

Related Content:

MedicalRegulatoryBreaking News
Tips and tricks for diagnosing canine osteoarthritis early
Tips and tricks for diagnosing canine osteoarthritis early
Performing surgery on dogs with GDV
Performing surgery on dogs with GDV
Not-so-ordinary ER cases you should know
Not-so-ordinary ER cases you should know

Advertisement

Latest News

Thriving when life is hard

Hospital design expert shares his favorite design element

Updated EquiTrace app integrates wth HISA Portal

San Francisco SPCA receives $100k grant from San Francisco Foundation

View More Latest News
Advertisement